Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Infertility | D007246 | HP_0000789 | — | — | 1 | — | — | — | 1 |
Premature obstetric labor | D007752 | — | O60 | — | 1 | — | — | — | 1 |
Premature birth | D047928 | EFO_0003917 | O60 | — | 1 | — | — | — | 1 |
Drug common name | BARUSIBAN |
INN | barusiban |
Description | Barusiban (INN) (code name FE-200440) is a non-peptide drug which is among the most potent and selective oxytocin receptor antagonists known. It was trialed by Ferring Pharmaceuticals as a treatment of preterm labor but failed to demonstrate effectiveness and was not pursued any further.
|
Classification | Protein |
Drug class | oxytocin antagonists |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC[C@H](C)[C@@H]1NC(=O)[C@@H](Cc2c[nH]c3ccccc23)NC(=O)CCSCC[C@@H](C(=O)N(C)[C@H](CO)CCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H]([C@H](C)CC)NC1=O |
PDB | — |
CAS-ID | 285571-64-4 |
RxCUI | — |
ChEMBL ID | CHEMBL2218898 |
ChEBI ID | — |
PubChem CID | 9832431 |
DrugBank | — |
UNII ID | UX33I93GLS (ChemIDplus, GSRS) |